GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Intrinsic Value: Projected FCF

Shanghai INT Medical Instruments Co (HKSE:01501) Intrinsic Value: Projected FCF : HK$3.03 (As of Jun. 27, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-06-27), Shanghai INT Medical Instruments Co's Intrinsic Value: Projected FCF is HK$3.03. The stock price of Shanghai INT Medical Instruments Co is HK$25.00. Therefore, Shanghai INT Medical Instruments Co's Price-to-Intrinsic-Value-Projected-FCF of today is 8.3.

The historical rank and industry rank for Shanghai INT Medical Instruments Co's Intrinsic Value: Projected FCF or its related term are showing as below:

HKSE:01501' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 8.23   Med: 10.49   Max: 13.24
Current: 8.25

During the past 9 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Shanghai INT Medical Instruments Co was 13.24. The lowest was 8.23. And the median was 10.49.

HKSE:01501's Price-to-Projected-FCF is ranked worse than
92.19% of 384 companies
in the Medical Devices & Instruments industry
Industry Median: 1.545 vs HKSE:01501: 8.25

Shanghai INT Medical Instruments Co Intrinsic Value: Projected FCF Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co Intrinsic Value: Projected FCF Chart

Shanghai INT Medical Instruments Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only - - 2.74 2.16 3.03

Shanghai INT Medical Instruments Co Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.74 - 2.16 - 3.03

Competitive Comparison of Shanghai INT Medical Instruments Co's Intrinsic Value: Projected FCF

For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai INT Medical Instruments Co's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai INT Medical Instruments Co's Price-to-Projected-FCF falls into.


;
;

Shanghai INT Medical Instruments Co Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Shanghai INT Medical Instruments Co's Free Cash Flow(6 year avg) = HK$-67.19.

Shanghai INT Medical Instruments Co's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Dec24)*0.8)/Shares Outstanding (Diluted Average)
=(14.862653310476*-67.193+1894.293*0.8)/170.678
=3.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai INT Medical Instruments Co  (HKSE:01501) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Shanghai INT Medical Instruments Co's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=25.00/3.0277372368389
=8.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai INT Medical Instruments Co Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai INT Medical Instruments Co Business Description

Traded in Other Exchanges
N/A
Address
No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803
Shanghai INT Medical Instruments Co Ltd engages in the design and development of medical devices used in fields including peripheral intervention, neurological intervention, cardiovascular intervention, or implantation, and the design and development of equipment and moulds used for the production of medical devices. The company operates in the Chinese Mainland, Europe, the United States, and Other countries and regions. The majority of the revenue comes from the Chinese Mainland.
Executives
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
China Orient Asset Management (international) Holding Limited 2201 Interest of corporation controlled by you
Zhao Wei 2202 Interest of your spouse
Wang Kai 2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership) 2101 Beneficial owner
Ningbo Huaige Health Investment Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Central Huijin Investment Ltd. 2201 Interest of corporation controlled by you
Orbimed Capital Llc 2102 Investment manager
Zhao Wei 2202 Interest of your spouse
Zheng Aiping 2501 Other
Zhang Xianmiao 2501 Other
Zhang Wei 2501 Other
Shanghai Kindly Holding Group Co., Ltd. 2201 Interest of corporation controlled by you
Worldwide Healthcare Trust Plc 2101 Beneficial owner

Shanghai INT Medical Instruments Co Headlines

No Headlines